Background Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis
after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of …

Neointimal hyperplasia, a pathological response to arterial interventions or injury, often
leads to restenosis and recurrent narrowing or occlusion, particularly in the peripheral …

Background: A recent summary-level meta-analysis comprising randomized, controlled trials
(RCTs) of femoropopliteal paclitaxel-coated balloon and stent intervention identified excess …

Objectives: The aim of this study was to appraise 2-year outcomes after percutaneous
transluminal angioplasty of long femoropopliteal artery disease using paclitaxel-coated …

Purpose A controlled, prospective, multicenter, randomized trial to compare primary patency
after angioplasty with a drug-coated balloon versus plain angioplasty balloon in stenosis of …

Drug-coated balloon therapy is a minimally-invasive endovascular approach to treat
obstructive arterial disease, with increasing utilization in the peripheral circulation due to …

Background Arterial restenosis after vascular surgery is a common cause of midterm
restenosis and treatment failure. Herein, we aim to investigate the role of microbe‐derived …

Background: There are limited data comparing the outcomes of subintimal vs. intraluminal
approach in the treatment of long femoropopliteal artery occlusions. The objective of this …

Objective Common femoral artery (CFA) occlusive disease remains a debatable site for
endovascular therapy, and the outcome of drug-eluting balloon (DEB) angioplasty in treating …

Background This quantitative meta-analysis was conducted to evaluate the efficacy and
safety of drug-eluting balloon (DEB) vs. uncoated balloon (UCB) in patients with …